论文部分内容阅读
Chimeric antigen receptor-T-cell therapy: China leading the way
【机 构】
：
Imperial College of Science, Technology and Medicine, London, UK
【发表日期】
：
2022年04期
其他文献
A typical bedside-to-bench investigation of leukemogenic driver MEF2D fusion reveals new targeted th
Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer vi
Comprehensive view on genetic features, therapeutic modalities and prognostic models in adult T-cell